| Schedule of Weighted Average Dilutive Common Shares Anti-dilutive |
The
common stock equivalents associated with the following securities are excluded from the calculation of weighted average dilutive common
shares because their inclusion would have been anti-dilutive:
Schedule
of Weighted Average Dilutive Common Shares Anti-dilutive
| | |
December
31, | |
| | |
2024 | | |
2023 | |
| | |
| | |
| |
| Options | |
| 6,932,004 | | |
| 6,932,004 | |
| Warrants | |
| 20,769,303 | | |
| 15,438,607 | |
| Convertible notes [1] | |
| 15,246,652 | | |
| 13,331,062 | |
| Convertible preferred
stock | |
| 21,464,713 | | |
| 19,863,450 | |
| Total | |
| 64,412,672 | | |
| 55,565,123 | |
| [1] |
Convertible
notes are assumed to be converted at the rate of $0.75 per common share, which is the conversion
price as of December 31, 2024 and 2023. However, as further described in Note 8, Notes
Payable, such conversion rates are subject to adjustment under certain circumstances,
such as stock splits and stock dividends, which may result in the issuance of common shares
greater than the amount indicated. |
|